GB201816399D0 - Cell - Google Patents

Cell

Info

Publication number
GB201816399D0
GB201816399D0 GBGB1816399.8A GB201816399A GB201816399D0 GB 201816399 D0 GB201816399 D0 GB 201816399D0 GB 201816399 A GB201816399 A GB 201816399A GB 201816399 D0 GB201816399 D0 GB 201816399D0
Authority
GB
United Kingdom
Prior art keywords
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1816399.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autolus Ltd
Original Assignee
Autolus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autolus Ltd filed Critical Autolus Ltd
Priority to GBGB1816399.8A priority Critical patent/GB201816399D0/en
Publication of GB201816399D0 publication Critical patent/GB201816399D0/en
Priority to PCT/GB2019/052829 priority patent/WO2020074868A1/en
Priority to EP19791327.0A priority patent/EP3864034A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/7051T-cell receptor (TcR)-CD3 complex
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/461Cellular immunotherapy characterised by the cell type used
    • A61K39/4611T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/463Cellular immunotherapy characterised by recombinant expression
    • A61K39/4631Chimeric Antigen Receptors [CAR]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/464Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643Vertebrate antigens
    • A61K39/4644Cancer antigens
    • A61K39/464469Tumor associated carbohydrates
    • A61K39/464471Gangliosides, e.g. GM2, GD2 or GD3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70521CD28, CD152
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0636T lymphocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50Cell markers; Cell surface determinants
    • C12N2501/515CD3, T-cell receptor complex
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
GBGB1816399.8A 2018-10-08 2018-10-08 Cell Ceased GB201816399D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB1816399.8A GB201816399D0 (en) 2018-10-08 2018-10-08 Cell
PCT/GB2019/052829 WO2020074868A1 (en) 2018-10-08 2019-10-07 Cell
EP19791327.0A EP3864034A1 (en) 2018-10-08 2019-10-07 Cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1816399.8A GB201816399D0 (en) 2018-10-08 2018-10-08 Cell

Publications (1)

Publication Number Publication Date
GB201816399D0 true GB201816399D0 (en) 2018-11-28

Family

ID=64397609

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1816399.8A Ceased GB201816399D0 (en) 2018-10-08 2018-10-08 Cell

Country Status (3)

Country Link
EP (1) EP3864034A1 (en)
GB (1) GB201816399D0 (en)
WO (1) WO2020074868A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115181751A (en) * 2021-04-02 2022-10-14 苏州博腾生物制药有限公司 Chimeric antigen receptors targeting albumin and methods of use thereof

Also Published As

Publication number Publication date
EP3864034A1 (en) 2021-08-18
WO2020074868A1 (en) 2020-04-16

Similar Documents

Publication Publication Date Title
GB201813178D0 (en) Cell
GB2577114B (en) Battery
IL273915A (en) Cell
GB201901307D0 (en) Electrolytes
GB201803079D0 (en) Cell
PL3654417T3 (en) Battery
GB201707783D0 (en) Cell
GB201707779D0 (en) Cell
GB201713078D0 (en) T Cell Modification
GB2577261B (en) Battery
GB201720949D0 (en) Cell
GB201819540D0 (en) T cell modification
GB201718697D0 (en) Cell
GB201904971D0 (en) Cell
GB201815190D0 (en) Battery compartent
GB201906202D0 (en) Cell
GB201807693D0 (en) Cell
GB201818625D0 (en) Battery
EP4048783C0 (en) Modified cell
GB201816399D0 (en) Cell
GB201805918D0 (en) Cell
CA201678S (en) Battery
GB201804917D0 (en) Battery
GB201714718D0 (en) Cell
GB2577995B (en) Cell

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)